从植物遗传资源到化品活性成分:当科学与监管和市场规则相遇时
F Bourgaud1, R M Twyman2, K-M Oksman-Caldentey3
1Université de Lorraine, CNRS, LRGP, F-54000, Nancy, France.
Open research Europe
|October 6, 2025
概括
消费者越来越多地要求可持续的化品成分. 本综述探讨了植物化品的法规和生物技术,重点是InnCoCells项目.
科学领域:
- 化品科学 化品科学
- 生物技术是生物技术.
- 监管事务 监管事务
背景情况:
- 越来越多的消费者对环境影响的认识推动了对可持续化品成分的需求.
- 现代化品成分需要安全性,有效性和可持续性,通过复杂的全球法规来导航.
- 关于可持续性声明的认证计划通常定义不完善,并且重叠.
研究的目的:
- 审查管理植物化品成分的法规.
- 检查法规与生物技术方法在成分开发方面的交叉关系.
- 展示InnCoCells项目作为可持续化品成分创新的模式.
主要方法:
- 关于法规和科学出版物的文献综述.
- 分析生物技术与监管框架之间的相互作用.
- 关于InnCoCells Horizon项目的案例研究介绍.
主要成果:
- 确定了植物化品成分的关键监管挑战.
- 突出了生物技术如何满足有效性和可持续性的需求.
- 证明InnCoCells在推动可持续化品成分开发中的作用.
结论:
- 有效的法规导航对于可持续的植物化品成分至关重要.
- 生物技术为开发符合标准,有效和可持续的原料提供了强大的工具.
- 像InnCoCells这样的项目对于未来的环保化品至关重要.
相关概念视频
Transgenic Plants
8.4K
Recombinant DNA technology called transgenesis is often used to add a foreign gene or remove a detrimental gene from an organism. Such genetically modified organisms are called transgenic organisms.
The first-ever transgenic plant was a tobacco plant developed in 1983 that showed resistance against the tobacco mosaic virus. Since then, many transgenic plants have been developed and commercialized for improving the agricultural, ornamental, and horticultural value of a crop plant. Transgenic...
The first-ever transgenic plant was a tobacco plant developed in 1983 that showed resistance against the tobacco mosaic virus. Since then, many transgenic plants have been developed and commercialized for improving the agricultural, ornamental, and horticultural value of a crop plant. Transgenic...
8.4K
Plant Breeding and Biotechnology
21.5K
Crop cultivation has a long history in human civilization, with records showing the cultivation of cereal plants beginning at around 8000 BC. This early plant breeding was developed primarily to provide a steady supply of food.
21.5K
Drug Regulation
2.7K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
2.7K
Drug Products: Biologics, Biosimilars and Interchangeables
233
Body:Biologics, derived from living sources such as humans, animals, or microorganisms, represent a significant category of pharmaceuticals. These complex molecules, developed through advanced biotechnological methods or purified from natural sources, include essential medical treatments like insulin and growth hormones. The complexity of biologics arises from their large molecular structures and the intricate processes required for their production, making them distinct from conventional...
233
Preclinical Development: Overview
5.8K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
5.8K
Clinically Relevant Drug Product Specifications: Methods of Establishment
203
Product specifications define the acceptable quality of a pharmaceutical product by ensuring identity, purity, potency, and strength. These specifications serve as benchmarks during development, manufacturing, and post-approval quality control. Clinically relevant specifications are particularly important because they directly relate to a drug's safety and efficacy in clinical use.Dissolution studies are critical biopharmaceutic tools that link in vitro behavior to in vivo performance. They...
203


